Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell surface integrins and extracellular matrix (ECM) receptors represent a broad class of transmembrane proteins that facilitate the physical attachment of cells to the surrounding matrix and neighboring cells (Source: StatPearls, Integrins). Integrins, the most extensively studied members of this group, are heterodimeric complexes consisting of alpha and beta subunits that bridge the ECM to the intracellular actin cytoskeleton, enabling bidirectional signaling known as inside-out and outside-in signaling (Source: UniProt). These receptors are fundamental to physiological processes including cell adhesion, migration, and survival, but their dysregulation is a hallmark of various pathologies such as cancer metastasis, chronic inflammation, and fibrotic disorders (Source: Nature Reviews Molecular Cell Biology). Because this entry describes a functional grouping rather than a single molecular entity, it is classified as a broad target class. Therapeutic interventions targeting specific members of this family, such as alpha-4 or alpha-IIb-beta-3 integrins, have been successfully developed for treating conditions like multiple sclerosis, inflammatory bowel disease, and acute coronary syndrome (Source: DrugBank).
Inhibition of ligand binding to the receptor complex, preventing cell-matrix or cell-cell adhesion and downstream signaling cascades.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cell surface integrins and extracellular matrix receptors.